Bristol/Sanofi’s Plavix Settlement Denied Antitrust Clearance
This article was originally published in The Pink Sheet Daily
Executive Summary
States attorneys general reject a proposed settlement one day after the companies announced they are facing a related DoJ criminal investigation.
You may also be interested in...
Apotex Alleges Bristol/Sanofi Misled Regulators On Plavix Settlement
Bristol/Sanofi made oral commitments to Apotex that were not included in a written settlement, Apotex claims in court documents.
Apotex Alleges Bristol/Sanofi Misled Regulators On Plavix Settlement
Bristol/Sanofi made oral commitments to Apotex that were not included in a written settlement, Apotex claims in court documents.
Plavix Generic Launch May Be Imminent
The potential of an at-risk launch of a generic Plavix led Medco to raise its earnings estimates, partially reflecting additional savings the Apotex generic could bring.